253 related articles for article (PubMed ID: 10383928)
1. Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat.
Letrent SP; Pollack GM; Brouwer KR; Brouwer KL
Drug Metab Dispos; 1999 Jul; 27(7):827-34. PubMed ID: 10383928
[TBL] [Abstract][Full Text] [Related]
2. Influence of biophase distribution and P-glycoprotein interaction on pharmacokinetic-pharmacodynamic modelling of the effects of morphine on the EEG.
Groenendaal D; Freijer J; de Mik D; Bouw MR; Danhof M; de Lange EC
Br J Pharmacol; 2007 Jul; 151(5):713-20. PubMed ID: 17471181
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetic modelling of non-linear brain distribution of morphine: influence of active saturable influx and P-glycoprotein mediated efflux.
Groenendaal D; Freijer J; de Mik D; Bouw MR; Danhof M; de Lange EC
Br J Pharmacol; 2007 Jul; 151(5):701-12. PubMed ID: 17471182
[TBL] [Abstract][Full Text] [Related]
4. Effect of GF120918, a potent P-glycoprotein inhibitor, on morphine pharmacokinetics and pharmacodynamics in the rat.
Letrent SP; Pollack GM; Brouwer KR; Brouwer KL
Pharm Res; 1998 Apr; 15(4):599-605. PubMed ID: 9587957
[TBL] [Abstract][Full Text] [Related]
5. Effects of quinidine on antinociception and pharmacokinetics of morphine in rats.
Okura T; Morita Y; Ito Y; Kagawa Y; Yamada S
J Pharm Pharmacol; 2009 May; 61(5):593-7. PubMed ID: 19405997
[TBL] [Abstract][Full Text] [Related]
6. Increased oral bioavailability of paclitaxel by GF120918 in mice through selective modulation of P-glycoprotein.
Bardelmeijer HA; Beijnen JH; Brouwer KR; Rosing H; Nooijen WJ; Schellens JH; van Tellingen O
Clin Cancer Res; 2000 Nov; 6(11):4416-21. PubMed ID: 11106262
[TBL] [Abstract][Full Text] [Related]
7. Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine.
Kharasch ED; Hoffer C; Whittington D; Sheffels P
Clin Pharmacol Ther; 2003 Dec; 74(6):543-54. PubMed ID: 14663457
[TBL] [Abstract][Full Text] [Related]
8. Blood-brain barrier transport helps to explain discrepancies in in vivo potency between oxycodone and morphine.
Boström E; Hammarlund-Udenaes M; Simonsson US
Anesthesiology; 2008 Mar; 108(3):495-505. PubMed ID: 18292687
[TBL] [Abstract][Full Text] [Related]
9. Systemic coadministration of chloramphenicol with intravenous but not intracerebroventricular morphine markedly increases morphine antinociception and delays development of antinociceptive tolerance in rats.
Smith MT; Nielsen CK; Lim-Fraser MY; Wright AW; Lau M
Drug Metab Dispos; 2000 Feb; 28(2):236-44. PubMed ID: 10640523
[TBL] [Abstract][Full Text] [Related]
10. Differential in vivo sensitivity to inhibition of P-glycoprotein located in lymphocytes, testes, and the blood-brain barrier.
Choo EF; Kurnik D; Muszkat M; Ohkubo T; Shay SD; Higginbotham JN; Glaeser H; Kim RB; Wood AJ; Wilkinson GR
J Pharmacol Exp Ther; 2006 Jun; 317(3):1012-8. PubMed ID: 16537797
[TBL] [Abstract][Full Text] [Related]
11. Blood-brain barrier transport of morphine in patients with severe brain trauma.
Ederoth P; Tunblad K; Bouw R; Lundberg CJ; Ungerstedt U; Nordström CH; Hammarlund-Udenaes M
Br J Clin Pharmacol; 2004 Apr; 57(4):427-35. PubMed ID: 15025740
[TBL] [Abstract][Full Text] [Related]
12. Increase in morphine antinociceptive activity by a P-glycoprotein inhibitor in cisplatin-induced neuropathy.
Balayssac D; Cayre A; Ling B; Maublant J; Penault-Llorca F; Eschalier A; Coudoré F; Authier N
Neurosci Lett; 2009 Nov; 465(1):108-12. PubMed ID: 19733628
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic-pharmacodynamic modelling of morphine transport across the blood-brain barrier as a cause of the antinociceptive effect delay in rats--a microdialysis study.
Bouw MR; Gårdmark M; Hammarlund-Udenaes M
Pharm Res; 2000 Oct; 17(10):1220-7. PubMed ID: 11145227
[TBL] [Abstract][Full Text] [Related]
14. A simplified protocol employing elacridar in rodents: a screening model in drug discovery to assess P-gp mediated efflux at the blood brain barrier.
Kallem R; Kulkarni CP; Patel D; Thakur M; Sinz M; Singh SP; Mahammad SS; Mandlekar S
Drug Metab Lett; 2012 Jun; 6(2):134-44. PubMed ID: 23061481
[TBL] [Abstract][Full Text] [Related]
15. Quantitative investigation of the impact of P-glycoprotein inhibition on drug transport across blood-brain barrier in rats.
Sugimoto H; Hirabayashi H; Kimura Y; Furuta A; Amano N; Moriwaki T
Drug Metab Dispos; 2011 Jan; 39(1):8-14. PubMed ID: 20962062
[TBL] [Abstract][Full Text] [Related]
16. Blood-brain barrier transport and brain distribution of morphine-6-glucuronide in relation to the antinociceptive effect in rats--pharmacokinetic/pharmacodynamic modelling.
Bouw MR; Xie R; Tunblad K; Hammarlund-Udenaes M
Br J Pharmacol; 2001 Dec; 134(8):1796-804. PubMed ID: 11739257
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein ATPase activating effect of opioid analgesics and their P-glycoprotein-dependent antinociception in mice.
Hamabe W; Maeda T; Fukazawa Y; Kumamoto K; Shang LQ; Yamamoto A; Yamamoto C; Tokuyama S; Kishioka S
Pharmacol Biochem Behav; 2006 Nov; 85(3):629-36. PubMed ID: 17134744
[TBL] [Abstract][Full Text] [Related]
18. Altered brain exposure of morphine in experimental meningitis studied with microdialysis.
Tunblad K; Ederoth P; Gärdenfors A; Hammarlund-Udenaes M; Nordström CH
Acta Anaesthesiol Scand; 2004 Mar; 48(3):294-301. PubMed ID: 14982561
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of alfentanil in P-glycoprotein-competent and P-glycoprotein-deficient mice: P-glycoprotein efflux alters alfentanil brain disposition and antinociception.
Kalvass JC; Olson ER; Pollack GM
Drug Metab Dispos; 2007 Mar; 35(3):455-9. PubMed ID: 17178769
[TBL] [Abstract][Full Text] [Related]
20. Sex-related differences in morphine's antinociceptive activity: relationship to serum and brain morphine concentrations.
Cicero TJ; Nock B; Meyer ER
J Pharmacol Exp Ther; 1997 Aug; 282(2):939-44. PubMed ID: 9262361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
